Larotrectinib Price 2023

Larotrectinib is a targeted anti-cancer drug that belongs to a class of drugs called "TRKinhibitors". It is designed to target patients with tumors that have specific genetic mutations, specifically those with NTRK gene fusions (NTRK fusions).

Larotrectinib has been launched in China, but it has not yet been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it in China. Please consult the local hospital pharmacy for details. There are original drugs and generic drugs of larotrectinib abroad. The original drugs include German version, American version, European version and Hong Kong version. The price is basically around 20,000 yuan. Generic drugs include Lao and Bangladeshi versions, with prices ranging from two to three thousand. The ingredients of original drugs and generic drugs are basically the same.

The primary indication for larotrectinib is the treatment of tumors harboringNTRK gene fusions. This includes both pediatric and adult patients. NTRKGene fusion is a rare but genetic abnormality seen in many cancer types, including some solid tumors in children and adults.

The mechanism of action of larotrectinib is to inhibit the growth and spread of tumor cells by targetingNTRK fusion protein. NTRKgene fusion can lead to abnormally active TRK protein, which plays a key role in promoting the development of tumors. Larotrectinib fights these tumors by blocking the activity of the TRK protein.

The efficacy of larotrectinib has been verified in multiple clinical trials. In some studies, larotrectinib has shown significant therapeutic effects in patients with tumors harboringNTRKgene fusions. For these patients, it can lead to partial or complete remission of the tumor and improve quality of life.